Long-term clinical, virological and immunological outcomes in patients hospitalized for COVID-19: antibody response predicts long COVID

J Garc�a-Abell�n, S Padilla, M Fern�ndez-Gonz�lez…�- medRxiv, 2021 - medrxiv.org
Objective Long-term data following SARS-CoV-2 infection are limited. We aimed to
characterize the medium and long-term clinical, virological, and immunological outcomes
after hospitalization for COVID-19, and to identify predictors of long-COVID. Methods
Prospective, longitudinal study conducted in COVID-19 patients confirmed by RT-PCR.
Serial blood and nasopharyngeal samples (NPS) were obtained for measuring SARS-CoV-
2 RNA and S-IgG/N-IgG antibodies during hospital stay, and at 1, 2 and 6 months post�…

[HTML][HTML] Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study

J Garc�a-Abell�n, S Padilla…�- Journal of clinical�…, 2021 - Springer
Background The relationship of host immune response and viral replication with health
outcomes in patients with COVID-19 remains to be defined. We aimed to characterize the
medium and long-term clinical, virological, and serological outcomes after hospitalization for
COVID-19, and to identify predictors of long-COVID. Methods Prospective, longitudinal study
conducted in COVID-19 patients confirmed by RT-PCR. Serial blood and nasopharyngeal
samples (NPS) were obtained for measuring SARS-CoV-2 RNA and S-IgG/N-IgG antibodies�…
Showing the best results for this search. See all results